ReviewFrontiers in cardiovascular medicine2026
Infections in mechanical circulatory support.
Review in Frontiers in cardiovascular medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Mechanical circulatory support (MCS) devices represent a major advance in the management of advanced heart failure and cardiogenic shock. Despite significant improvements in device technology and patient outcomes, infection remains the most common adverse event, affecting approximately 37% of patients and contributing substantially to morbidity and mortality. This state-of-the-art, multidisciplinary review comprehensively examines infections in patients who require durable or temporary mechanical circulatory support devices with contributions from experts in advanced heart failure, cardiovascular imaging, infectious diseases, cardiothoracic surgery, and pharmacology. We review the underlying pathophysiology of MCS-related infections, examine current preventative, diagnostic and management strategies, outline established best practices, discuss emerging technologies and therapies, and identify existing knowledge gaps and areas for future investigation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.